Biggest stock gainers

$SOFI - Shares rose after Citizens upgraded the stock to Market Outperform from Market Perform, citing an overdone selloff tied to risk-off rotation rather than fundamentals. Analyst Devin Ryan said recent weakness reflects style factor compression and technicals, while the business continues to execute and expand. Citizens set a $30 price target, implying about 44% upside from the prior close.
$KR- Shares advanced after The Wall Street Journal reported the grocer plans to appoint former Walmart U.S. chief Greg Foran as its next CEO, ending a months-long search following Rodney McMullen’s exit. Foran would take over at a pivotal time as Kroger navigates food-price pressures, heightened competition from discount grocers, and its post–Albertsons strategy after the $20B deal collapsed in 2024.
$WULF and Cipher Mining (CIFR) +2% - Shares rose after Morgan Stanley initiated coverage with an Overweight rating on both names, citing attractive valuations tied to Bitcoin-to-data center conversions. Analyst Stephen Byrd said AI players are increasingly willing to pay higher “time to power” premia, creating richer economics for Bitcoin miners with valuable power access. Morgan Stanley set a $37 price target on Terawulf and $38 on Cipher Mining, each implying an upside of about 159%.
Biggest stock losers
$HIMS- Shares plunged after the company said it will stop offering a compounded, copycat version of Novo Nordisk’s Wegovy (semaglutide) pill, following pressure from Novo and heightened FDA scrutiny. In a post on X, the company said it decided to discontinue the treatment after “constructive conversations” with industry stakeholders. The move comes after FDA Commissioner Marty Makary said regulators would target companies producing mass-market copycat drugs, raising broader concerns around compounded GLP-1 offerings.